Through the 90-day period concluding January 10, 2026, Intellia Therapeutics's top three insider stakeholders include President And Ceo John M Leonard (1.01Mn shares), Director Fred E Cohen (207.45K shares), Evp And General Counsel Jose E Rivera (162.39K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| John M Leonard | President And Ceo | 1,013,339 | 07 Jan, 2026 |
| Fred E Cohen | 207,453 | 07 Jan, 2026 | |
| Jose E Rivera | Evp And General Counsel | 162,388 | 02 Apr, 2021 |
| William J Chase | 134,693 | 22 Aug, 2025 | |
| David Lebwohl | Evp And Chief Medical Officer | 121,249 | 07 Jan, 2026 |
| James Basta | Evp And General Counsel | 101,528 | 07 Jan, 2026 |
| Edward J Iii Dulac | Evp And Chief Financial Officer | 99,683 | 07 Jan, 2026 |
| Birgit C Schultes | Evp And Chief Scientific Officer | 98,533 | 07 Jan, 2026 |
| Eliana Clark | Evp And Chief Technical Officer | 87,118 | 07 Jan, 2026 |
| Laura Sepp-Lorenzino | Evp And Chief Scientific Officer | 77,388 | 07 Jan, 2025 |
| Glenn Goddard | Evp And Chief Financial Officer | 69,213 | 05 Mar, 2024 |
| Derek Hicks | Evp And Chief Business Officer | 59,878 | 07 Jan, 2025 |
| Michael P Dube | Vp And Chief Accounting Officer | 52,277 | 07 Jan, 2026 |
| Georgia Keresty | 31,883 | 18 Jun, 2025 | |
| Muna Bhanji | 27,203 | 13 Jun, 2025 | |
| Frank Verwiel | 25,948 | 13 Jun, 2025 | |
| Jesse Goodman | 24,359 | 02 Jul, 2025 | |
| Brian Goff | 23,409 | 13 Jun, 2025 | |
| Jean Francois Formela | 17,291 | 16 Jun, 2022 | |
| Caroline Dorsa | 12,701 | 16 Jun, 2022 | |
| John F Crowley | 11,716 | 16 Jun, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jan, 2026 | Fred E Cohen | Common Stock | A | 150,000 | $9.35 | 207,453 | D | P |
| 05 Jan, 2026 | John M Leonard | Common Stock | D | 34,146 | $9.21 | 1,013,339 | D | S |
| 05 Jan, 2026 | James Basta | Common Stock | D | 10,397 | $9.21 | 101,528 | D | S |
| 05 Jan, 2026 | David Lebwohl | Common Stock | D | 11,903 | $9.21 | 121,249 | D | S |
| 05 Jan, 2026 | Edward J Iii Dulac | Common Stock | D | 6,379 | $9.21 | 99,683 | D | S |
| 05 Jan, 2026 | Eliana Clark | Common Stock | D | 9,515 | $9.21 | 87,118 | D | S |
| 05 Jan, 2026 | Michael P Dube | Common Stock | D | 2,989 | $9.21 | 52,277 | D | S |
| 05 Jan, 2026 | Birgit C Schultes | Common Stock | D | 8,508 | $9.21 | 98,533 | D | S |
| 12 Dec, 2025 | John M Leonard | Common Stock | A | 8,557 | $6.83 | 1,047,485 | D | M |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 32,832 | $9.47 | 1,044,283 | D | S |
| 11 Dec, 2025 | John M Leonard | Common Stock | A | 49,959 | $6.83 | 1,127,074 | D | M |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 49,959 | $9.49 | 1,077,115 | D | S |
| 11 Dec, 2025 | John M Leonard | Common Stock | D | 5,355 | $9.59 | 1,038,928 | D | S |
| 01 Oct, 2025 | Michael P Dube | Common Stock | D | 1,871 | $17.38 | 55,266 | D | S |
| 01 Oct, 2025 | Birgit C Schultes | Common Stock | D | 31 | $17.38 | 105,184 | D | S |
| 20 Aug, 2025 | William J Chase | - | - | 134,693 | D | |||
| 20 Aug, 2025 | William J Chase | Common Stock | A | 100,000 | $10.03 | 134,693 | D | P |
| 23 Jul, 2025 | Edward J Iii Dulac | - | - | 106,062 | D | |||
| 23 Jul, 2025 | Edward J Iii Dulac | Common Stock | D | 7,462 | $14.02 | 106,062 | D | S |
| 02 Jul, 2025 | Michael P Dube | Common Stock | D | 2,503 | $9.95 | 57,137 | D | S |